by more efficient management of pharmaceutical supplies. Administrative Expenses During 9M17, administrative expenses increased by 14% yoy due mainly to the increase of headcounts and salary rate in
mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. The company’s net income in
such as mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. Profit
provisions for litigation in the amount of 12 million baht and 2 subsidiaries have a provision for the litigation of 1.13 million baht. 4. Loss arising from change in fair value of biological assets increase
period (as of June 30, 2020 and 2019, respectively). 6. Loss arising from changes in fair value of biological assets increased by Baht 4.73 million compared with the same period of the previous year
by the end of accounting period (as of December 31, 2018 and 2017). - Other income from gain arising from change in fair value of biological assets which increased by amount of Baht 12 million
% Investment in associated company 483.96 36% 474.65 7% Property, plant and equipment 558.59 42% 557.68 5% Biological assets – dairy cow 44.28 3% 38.56 3% Others 61.09 4% 52.82 4% Total assets 1,345.45 100
8.34 million, or 26.62%, in the year 2021 cause was more commission income in of 2021, which decreased by Baht 12.76 million and gain from changes in fair value of biological assets - dairy cow to Baht
higher revenue per visit of non-social security category but also from the efficient cost control of medicine and supplies as well as staff. Administrative Expenses Administrative expenses decreased by 13
IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of